The minimally invasive RegenaDISC procedure is used to treat disc degeneration in the lumbar, thoracic and cervical spine. The procedure uses mesenchymal stem cells and is performed as an outpatient procedure.
The surgery relies on the adult stem cells’ capacity to produce proteoglycan, which heals and hydrates the damaged disc.
Read the Celling Treatment Centers release on the RegenaDISC procedure.
Read other coverage on Celling Treatment Centers:
– Latest Trends in Spine Surgery Techniques: Laser and Stem Cell Technology
– Orthopedic and Spine Industry Leader to Know: Dr. Mark Flood of Celling Treatment Centers
